Form 4: Solid Biosciences Director Ian F. Smith Reports Stock Unit Conversion
SEC Form 4
Director Ian F. Smith converted 3,255 restricted stock units into common stock of Solid Biosciences Inc. on July 3, 2024.
Summary
- On July 3, 2024, Ian F. Smith, a director of Solid Biosciences Inc., converted 3,255 restricted stock units into common stock.
- Following the transaction, Smith directly owns 106,462 shares of Solid Biosciences Inc.
- The restricted stock units were granted on January 3, 2024, and vest in equal quarterly installments over 12 months.
- The conversion occurred under the terms of the restricted stock unit agreement, where each unit converts into one share of common stock.
Sentiment
Score: 5
Explanation: This is a neutral event, reflecting scheduled vesting of stock units.
Positives
- The vesting schedule of the restricted stock units encourages long-term commitment from the director.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The conversion of stock units has a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| January 3, 2024 | Date the restricted stock units were granted. |
| July 3, 2024 | Date of the stock unit conversion. |
| July 5, 2024 | Date of the form filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.